News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Biogen (BIIB) Gained $1 Billion Overnight After Becoming Goldman Sachs' Favorite Biotech     8/17/2017
Heading Back to the Lab to Crack Alzheimer’s Disease     8/11/2017
Startup MyndYou Using AI to Treat Alzheimer’s Disease     8/9/2017
Another Alzheimer's Let-Down as FUJIFILM's Candidate Flunks Phase II Test     7/19/2017
Bay Area's E-Scape Bio Bursts Out of Stealth Mode With $63 Million to Tackle Alzheimer's     7/13/2017
Meet the 'Rock Star of Science' Obsessed With Stopping Alzheimer's     6/26/2017
BIO2017: Eli Lilly (LLY) Clinical Development Head Looks to Innovate, Continue Alzheimer’s Research     6/21/2017
BIO2017: Former UK Prime Minister Cameron Calls for More Alzheimer’s Research     6/21/2017
Is This Fake News? Neurotrope (NTRP) Alzheimer's Release Takes Weird Spin     5/5/2017
Analyzing Wild Optimism and Questionable Studies for Alzheimer’s Drug Development     4/28/2017
Some Predict Biogen (BIIB)’s Alzheimer’s Drug Will Fail     4/27/2017
Why This SoCal Pharma Could Be Your Best Bet on Alzheimer's     4/26/2017
Why Former Medivation (MDVN) CEO and a Once-Failed Alzheimer's Drug Could be a Recipe for Disaster for Axovant (AXON)     4/20/2017
Bristol-Myers Squibb (BMY) Inks Two Separate Pacts With Biogen (BIIB) and Roche (RHHBY) For a Total of Up to $1.1B     4/14/2017
A Look at Biogen (BIIB)'s Big Bet on the Holy Grail of Science—Alzheimer's     3/29/2017

News from Around the Web
Mapping The Brain's Microbiome: Can Studying Germs In The Brain Lead To A Cure For Alzheimer's?     7/31/2017
Genentech (RHHBY) R&D Exec Reveals Alzheimer's is Still A Priority     7/19/2017
Blood Test Identifies Key Alzheimer's Marker, Washington University School of Medicine Study Reveals     7/19/2017
In Alzheimer's, The 'Juggernaut Is Changing Course,' Says TauRx Pharma Chief Exec     7/18/2017
Your Insomnia Could Actually Lead To Alzheimer’s, Neurology Reveals     7/7/2017
Experts Discover 3 Things That Can Protect The Brain From Alzheimer's, National Academies of Sciences, Engineering, and Medicine Study Reveals     6/26/2017
Alzheimer's Drug Leads UBS To Upgrade Biogen (BIIB)     6/21/2017
Alzheimer's Affects Twice As Many People As Estimated, And The Numbers Are Climbing, USC Alzheimer's Therapeutic Research Institute (ATRI) Study Reveals     6/16/2017
‘Mini-Me’ Brains-In-A-Dish Mimic Disease, Raise Hope For Eventual Therapies, Nature Reveals     4/27/2017
Why Too Much Sugar Is Bad For Your Brain, Boston University School of Medicine Study Reveals     4/25/2017
Hopes Up On Lasers Kindling Lost Memories In Alzheimer’s Patients, MIT Reveals     3/31/2017
New Test May Predict Onset Of Alzheimer's, UCSF Study Reveals     3/22/2017
How This Biotech Phenom Plans To Speed Up Drug Research And Cure Alzheimer's     3/8/2017
Will BACE Inhibitors Help Alzheimer's Patients?     2/24/2017
Merck & Co. (MRK)'s Alzheimer's Failure Has All Eyes and Hopes Turning to Biogen (BIIB)     2/16/2017

Press Releases
Korea Institute Of Science And Technology (KIST) Develops A New Drug For Alzheimer's Disease     8/9/2017
University of Eastern Finland Release: Antiulcer Drugs Do Not Increase Risk Of Alzheimer’s Disease     8/7/2017
Pain Therapeutics (PTIE) Announces FDA Has Cleared An Investigational New Drug (IND) Application For PTI-125     7/31/2017
Neuronix Ltd. Announces The First Group Of Mild To Moderate Alzheimer Patients To Be Successfully Treated By The Neuroad Therapy System In London     7/25/2017
ORYZON Genomics Presents Final Data On The Phase I Trial With ORY-2001 At The Alzheimer's Association International Conference (AAIC-2017)     7/24/2017
Regenacy Pharma Presents Data Demonstrating That HDAC1,2 Inhibition Improved Cognitive Function In Mouse Models Of Alzheimer's Disease At The Alzheimer’s Association International Conference     7/20/2017
Feinstein Institute for Medical Research Release: Alzheimer's Drug Cuts Hallmark Inflammation Related To Metabolic Syndrome By 25 Percent     7/20/2017
Neurotrope (NTRP) Presents Phase II Data Assessing Bryostatin-1 In Moderate-To-Severe Alzheimer's Patients At AAIC 2017     7/19/2017
ProMis Neurosciences Presents At AAIC 2017 Data From Alzheimer's Disease Program     7/19/2017
Cognition Therapeutics Reports Drug-Drug Interaction Results For CT1812, A Disease-Modifying Alzheimer’s Disease Candidate     7/19/2017
Regenacy Pharma Presents Data Demonstrating That HDAC1,2 Inhibition Improved Cognitive Function In Mouse Models Of Alzheimer's Disease At The Alzheimer’s Association International Conference     7/19/2017
Alzheimer's Association Launches $20 Million Lifestyle Intervention Trial In The U.S. To Prevent Cognitive Decline     7/19/2017
EIP Pharma Announces Presentation Of New Mechanism Of Action Data Regarding Neflamapimod (VX-745) At Alzheimer's Association International Conference (AAIC)     7/19/2017
ModGene Pharma Announces Issuance Of U.S. Patent For Alzheimer's Disease Prevention     7/19/2017
EIP Pharma Announces Presentation Of New Positive Clinical Data With Neflamapimod (VX-745) At Alzheimer's Association International Conference (AAIC)     7/18/2017

//-->